Speakers

Expand/Collapse

Deepali Sawant
Senior Scientist, Oncology
Amgen

Preclinical Track - Day 1 pm

2:05 pm | Live Q&A

1:45 pm | GEM-Derived Allograft Models of Pancreatic Cancer: Valuable Tool for Preclinical Evaluation of Cominatorial Immunotherapies

Kimberly Aardalen
Scientific Technical Leader
Novartis Institutes for Biomedical Research

Dongfang Liu
Associate Professor & Director - Immunoassay Development Program
Rutgers New Jersey Medical School

Translation Track – Day 1 pm

1:50 pm | The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy

2:30 pm | Live Q&A

Brian Soper
Senior Technical Information Scientist
The Jackson Laboratory

Day One

Wednesday, July 14, 2021

4:40 pm | Panel Discussion: Organoids vs Humanized Mice - Modelling of the Tumor Landscape

Grace Berryhill
Senior Technical Information Scientist
The Jackson Laboratory

Day One

Wednesday, July 14, 2021

4:25 pm | Live Q&A - Ask Our Speakers Your Burning Questions

3:20 pm | New Humanized Mouse Models to Support NK Cell Research

Leo Price
Senior Vice President, In Vitro
Crown Bioscience

Day One

Wednesday, July 14, 2021

4:40 pm | Panel Discussion: Organoids vs Humanized Mice - Modelling of the Tumor Landscape

Preclinical Track - Day 1 pm

2:05 pm | Live Q&A

1:30 pm | Harnessing the Power of Next Gen In Vitro Models for Oncology Discovery & Development

Mark Moore
Chief Executive Officer
GemPharmatech

Day Two

Thursday, July 15, 2021

11:00 am | NCG Models for Engraftment of Human Immune Systems

12:15 pm | Live Q&A - Ask Our Speakers Your Burning Questions

Ganesh Mugundu
Head of Cell Therapy Clinical Pharmacology & Modelling
Takeda

Day Two

Thursday, July 15, 2021

10:05 am | Live Q&A

3:40 pm | Chair’s Closing Remarks & End of Summit

3:20 pm | Live Q&A - Ask Our Speakers Your Burning Questions

3:00 pm | Clinical Dosing - Clinical Pharmacology & Modelling of Cell Therapies

1:20 pm | Panel: Diversity & Inclusion in Preclinical & Translational Studies

12:15 pm | Live Q&A - Ask Our Speakers Your Burning Questions

8:45 am | Chair’s Opening Remarks

Rekha Pal
Director & Scientific Engagement
Crown Bioscience

Day One

Wednesday, July 14, 2021

10:20 am | Live Q&A - Ask Our Speakers Your Burning Questions

9:00 am | Translational Preclinical Platforms for CAR-T Cell Therapy

Aaron Goldman
Director, Drug Resistance Group
Harvard Medical School

Day Two

Thursday, July 15, 2021

10:05 am | Live Q&A

9:30 am | Blending Tumor Models and Engineering to Accelerate Natural Killer Cell Therapies in Glioblastoma Multiformel

Jonathan Nakashima
Chief Scientific Officer
Certis Oncology Solutions

Day Two

Thursday, July 15, 2021

10:05 am | Live Q&A

9:50 am | Orthotopic PDX Models Provide Relevant Tumor Microenvironments For Evaluating Cellular Therapies

Markus Vallaster
Senior Medical Director, Cell Therapies & Immuno-Oncology
AstraZeneca

Day Two

Thursday, July 15, 2021

3:20 pm | Live Q&A - Ask Our Speakers Your Burning Questions

2:20 pm | Translating Pre-Clinical Data into Innovative Clinical Trial Designs in Cell Therapies

Qingcong Lin
Chief Executive Officer
Biocytogen

Day Two

Thursday, July 15, 2021

10:05 am | Live Q&A

9:00 am | Use of Humanized Mouse Models for Better Translation in Immunotherapy

Kris Richardson
Senior Data Scientist
Berg Health

Natasha Darras
Director, Cell Therapy Translational Medicine
Takeda Oncology

Translation Track - Day 1 am

12:10 pm | Live Q&A

11:10 am | Using Single-Cell Omics to Better Understand Tumor Complexity

Irena Adkins
Pharmacology & Science Lead
SOTIO

Day Two

Thursday, July 15, 2021

1:20 pm | Panel: Diversity & Inclusion in Preclinical & Translational Studies

12:15 pm | Live Q&A - Ask Our Speakers Your Burning Questions

11:35 am | Understanding the Mechanistic Actions & Development of IL-15Rβγ Agonist

Shiva Kazerounian
Associate Director of in Vivo Pharmacology
Berg Health

Day One

Wednesday, July 14, 2021

5:25 pm | Chair’s Closing Remarks & End of Conference Day One

8:45 am | Chair’s Opening Remarks

Day Two

Thursday, July 15, 2021

1:20 pm | Panel: Diversity & Inclusion in Preclinical & Translational Studies

Translation Track - Day 1 am

12:10 pm | Live Q&A

11:30 am | Overcoming Cancer Drug Resistance

Simone Filosto
Principal Scientist, Translational Research & Clinical Pharmacology
Kite Pharma

Translation Track - Day 1 am

12:10 pm | Live Q&A

11:50 am | The Role of Translational Medicine in Supporting Product Developmen: An Axi-Cel Case Study

Chad May Senior
Vice President, Research & Development
Maverick Therapeutics

Day Two

Thursday, July 15, 2021

12:15 pm | Live Q&A - Ask Our Speakers Your Burning Questions

11:15 am | Conditionally Active COBRA T Cell Engagers Regress stablished Solid Tumors in Mice

Boris Engels
Associate Director
Novartis

Translation Track – Day 1 pm

2:30 pm | Live Q&A

1:30 pm | Assessing CAR-T Efficacy in Xenograft Models: Examples of Structure Activity Relationship

Aman Singh
Associate Director, Clinical Pharmacology M&S
Takeda

Day Two

Thursday, July 15, 2021

3:20 pm | Live Q&A - Ask Our Speakers Your Burning Questions

2:00 pm | Bench to Bedside Translation of Chimeric Antigen Receptor (CAR) T Cells Using a Multiscale Systems PKPD Model

Joshua Breunig
Associate Professor
Cedars-Sinai Medical Centre

Day One

Wednesday, July 14, 2021

4:40 pm | Panel Discussion: Organoids vs Humanized Mice - Modelling of the Tumor Landscape

4:25 pm | Live Q&A - Ask Our Speakers Your Burning Questions

3:50 pm | Comparison of New Syngeneic Mouse Models & Human Organoids with Single Cell Sequencing

Viswanathan Muthusamy
Research Scientist, Executive Director
Yale School of Medicine

Day Two

Thursday, July 15, 2021

12:15 pm | Live Q&A - Ask Our Speakers Your Burning Questions

11:55 am | Novel Preclinical Models for Investigation of Immune Oncology Therapeutics

Eric Ibsen
Chief Executive Officer
Studylog

Anton Neschadim
Chief Executive Officer & Director
ImmunoBiochem Corp

Translation Track – Day 1 pm

2:30 pm | Live Q&A

2:10 pm | Relevant Humanized Models for the Evaluation of Efficacy and Safety of Targeted Innate Immunity Agonists for Immuno-Oncology

Yufei Wang
Research Fellow Dana-Faber
Cancer Institute

Day One

Wednesday, July 14, 2021

4:40 pm | Panel Discussion: Organoids vs Humanized Mice - Modelling of the Tumor Landscape

10:20 am | Live Q&A - Ask Our Speakers Your Burning Questions

9:30 am | Evaluate Immune Restoring CAR-T Cell Therapy on Clear Cell Renal Cell Carcinoma (ccRCC) Patient Derived Rrganotypic Spheroids (PDOTs) & Humanized Mouse Model

Kader Thiam
Senior Vice President Discovery - Preclinical Models & Services
GenOway

Day One

Wednesday, July 14, 2021

10:20 am | Live Q&A - Ask Our Speakers Your Burning Questions

9:50 am | BRGSF-HIS Mouse: A Robust & Translatable New Model to Assess the Human Immune Response to Immunotherapies

Sheri Barnes
Associate Director - Scientific Development
Labcorp Drug Development

Day One

Wednesday, July 14, 2021

4:10 pm | Generation of a CD19-CAR T Cell Therapy as a Tool for Preclinical Combination Strategies

4:25 pm | Live Q&A - Ask Our Speakers Your Burning Questions

Rakesh Awasthi
Clinical Pharmacology, Pharmacokinetic Oncology Sciences & Investigator
Novartis

Day Two

Thursday, July 15, 2021

3:20 pm | Live Q&A - Ask Our Speakers Your Burning Questions

2:40 pm | Clinical Pharmacology of Tisagenlecleucel in Adult Relapsed/ Refractory DLBCL Patients

Martina Molgora
Postdoctoral Researcher Washington
University School of Medicine

Preclinical Track - Day 1 am

12:05 pm | Live Q&A

11:45 am | Innate Immune Checkpoints in Tumor Immunotherapy

Nikolaus Krall
Chief Executive Officer & Co-founder
Allcyte

Preclinical Track - Day 1 am

12:05 pm | Live Q&A

11:30 am | Enabling Patient-Centric Cancer R&D with Primary Tissues & Pharmacoscopy®

John Maher
Senior Lecturer - Clinical Immunology
King’s College London

Preclinical Track - Day 1 am

12:05 pm | Live Q&A

11:10 am | Parallel CAR Targetting of Solid Tumors in Xenograft Models